Mark E. Augspurger

1.5k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Mark E. Augspurger is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Mark E. Augspurger has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiation and 5 papers in Surgery. Recurrent topics in Mark E. Augspurger's work include Advanced Radiotherapy Techniques (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Mark E. Augspurger is often cited by papers focused on Advanced Radiotherapy Techniques (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Mark E. Augspurger collaborates with scholars based in United States, Canada and Spain. Mark E. Augspurger's co-authors include Walter H. Grant, Bin S. Teh, Samir Narayan, L.Steven Carpenter, Joseph Chiu, Shiao Y. Woo, Hsin H Lu, Adam Raben, Chen Hu and M.C. Dobelbower and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Journal of Thoracic Oncology.

In The Last Decade

Mark E. Augspurger

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

2016 528 citations Stephen G. Chun, Chen Hu et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Augspurger United States	10	764	481	345	181	179	15	1.1k
Sylvie Helfré France	16	602 0.8×	328 0.7×	296 0.9×	187 1.0×	100 0.6×	77	1.0k
Cinzia Iotti Italy	20	487 0.6×	379 0.8×	352 1.0×	182 1.0×	100 0.6×	80	953
Verity Ahern Australia	16	356 0.5×	297 0.6×	202 0.6×	162 0.9×	127 0.7×	56	856
Yoshiko Oshiro Japan	20	746 1.0×	397 0.8×	212 0.6×	118 0.7×	182 1.0×	71	1.2k
Yasser Abo‐Madyan Germany	19	680 0.9×	795 1.7×	442 1.3×	162 0.9×	162 0.9×	55	1.2k
Shigeyuki Murayama Japan	20	730 1.0×	400 0.8×	214 0.6×	194 1.1×	105 0.6×	64	1.1k
Neal Rebueno United States	14	628 0.8×	467 1.0×	336 1.0×	167 0.9×	162 0.9×	20	1.0k
D.N. Yeboa United States	16	476 0.6×	156 0.3×	171 0.5×	279 1.5×	311 1.7×	86	936
A. Muhs United States	13	601 0.8×	373 0.8×	348 1.0×	325 1.8×	67 0.4×	29	1.2k
Matthew D. Hall United States	15	459 0.6×	192 0.4×	166 0.5×	267 1.5×	195 1.1×	96	804

Countries citing papers authored by Mark E. Augspurger

Since Specialization

Citations

This map shows the geographic impact of Mark E. Augspurger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Augspurger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Augspurger more than expected).

Fields of papers citing papers by Mark E. Augspurger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Augspurger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Augspurger. The network helps show where Mark E. Augspurger may publish in the future.

Co-authorship network of co-authors of Mark E. Augspurger

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Augspurger. A scholar is included among the top collaborators of Mark E. Augspurger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Augspurger. Mark E. Augspurger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chun, Stephen G., Chen Hu, Ritsuko Komaki, et al.. (2024). Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer. JAMA Oncology. 10(8). 1111–1111. 10 indexed citations

Chun, Stephen G., Chen Hu, H. Choy, et al.. (2023). OA17.04 Long-Term Outcomes by Radiation Technique for Locally-Advanced Non-small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years. Journal of Thoracic Oncology. 18(11). S83–S84. 1 indexed citations

Kachnic, Lisa A., Kathryn Winter, Robert J. Myerson, et al.. (2021). Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. International Journal of Radiation Oncology*Biology*Physics. 112(1). 146–157. 31 indexed citations

Thor, Maria, Joseph O. Deasy, Chen Hu, et al.. (2018). The Role of Heart-Related Dose-Volume Metrics on Overall Survival in the RTOG 0617 Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 102(3). S96–S96. 5 indexed citations

Magliocco, Anthony, Jennifer Moughan, Jeffry Simko, et al.. (2017). The Impact of MRE11 in Nuclear to Cytoplasmic Ratio on Outcomes in Muscle Invasive Bladder Cancer: an Analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.. International Journal of Radiation Oncology*Biology*Physics. 99(2). S117–S118. 5 indexed citations

Magliocco, Anthony, Jennifer Moughan, Jeff Simko, et al.. (2017). The impact of MRE11 in nuclear to cytoplasmic ratio on outcomes in muscle invasive bladder cancer an analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.. Journal of Clinical Oncology. 35(6_suppl). 343–343. 9 indexed citations

Kachnic, Lisa A., Michael Goodyear, André Abitbol, et al.. (2017). NRG Oncology/RTOG 0529: Long-Term Outcomes of Dose-Painted Intensity Modulated Radiation Therapy, 5-Fluorouracil, and Mitomycin-C in Anal Canal Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S64–S65. 10 indexed citations

Glass, Jon, Minhee Won, Christopher J. Schultz, et al.. (2016). Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. Journal of Clinical Oncology. 34(14). 1620–1625. 101 indexed citations

Chun, Stephen G., Chen Hu, Hak Choy, et al.. (2016). Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. Journal of Clinical Oncology. 35(1). 56–62. 528 indexed citations breakdown →

10.

Chun, Stephen G., Chen Hu, H. Choy, et al.. (2015). Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617. International Journal of Radiation Oncology*Biology*Physics. 93(3). S1–S2. 24 indexed citations

11.

Woo, Shiao Y., Bin S. Teh, W. Mai, et al.. (2004). Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 58(3). 721–726. 105 indexed citations

12.

Augspurger, Mark E., Bin S. Teh, Haiquan Lu, et al.. (2004). Intensity modulated radiation therapy for optic nerve sheath meningioma. International Journal of Radiation Oncology*Biology*Physics. 60(1). S315–S315. 2 indexed citations

13.

Teh, Bin S., Mark E. Augspurger, Barry M Uhl, et al.. (2001). Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 49(2). 465–472. 76 indexed citations

14.

Teh, Bin S., W. Mai, Barry M Uhl, et al.. (2001). Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose–volume analysis. International Journal of Radiation Oncology*Biology*Physics. 49(3). 705–712. 156 indexed citations

15.

Augspurger, Mark E., et al.. (1999). 2091 Conformal intensity modulated radiation therapy for the treatment of optic nerve sheath meningioma. International Journal of Radiation Oncology*Biology*Physics. 45(3). 324–324. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact